Endovia Health Sciences (EDVA) Research & Development (2019 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Research & Development (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.70 Bn | 133.84 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.74 Bn | 1.37 Bn | -486.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 651.00 Mn |
| 5 | Revolution Medicines | 44.30 Bn | 44.30 Bn | - | 394.92 Mn |
| 6 | BeOne Medicines | 40.39 Bn | 35.29 Bn | 1.53 Bn | 612.28 Mn |
| 7 | Alnylam Pharmaceuticals | 35.40 Bn | 32.09 Bn | 992.69 Mn | 413.13 Mn |
| 8 | Royalty Pharma | 28.07 Bn | 27.24 Bn | - | 97.90 Mn |
| 9 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | 27,250.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27,250.00 |
| Mar 31, 2026 | 17,273.00 |
| Dec 31, 2025 | 10,517.00 |
| Sep 30, 2025 | 8,833.00 |
| Jun 30, 2025 | 12,769.00 |
| Mar 31, 2025 | 29,894.00 |
| Dec 31, 2024 | -161,672.00 |
| Sep 30, 2024 | 227,921.00 |
| Jun 30, 2024 | 214,812.00 |
| Mar 31, 2024 | 202,454.00 |
| Dec 31, 2023 | 387,961.00 |
| Sep 30, 2023 | 626,363.00 |
| Jun 30, 2023 | 742,369.00 |
| Mar 31, 2023 | 736,827.00 |
| Dec 31, 2022 | 888,468.00 |
| Sep 30, 2022 | 746,965.00 |
| Jun 30, 2022 | 665,059.00 |
| Mar 31, 2022 | 720,979.00 |
| Dec 31, 2021 | 322,122.00 |
| Sep 30, 2021 | 249,100.00 |